A controlled, open-label post-authorisation efficacy and safety study in imlifidase desensitised kidney transplant patients with

A controlled, open-label post-authorisation efficacy and safety study in imlifidase desensitised kidney transplant patients with positive crossmatch against a deceased donor prior to imlifidase treatment, including non-comparative registry and concurrent reference cohorts

Open

Protocol code: 20-HMedIdeS-19
EudraCT code: 2021-002640-70
Research group: Nephrology and kidney transplantation
Service: Nephrology
Principal investigator: Bestard Matamoros, Oriol
Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
Phase: Fase III
Status: Recruiting volunteers